Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122237
Filing Date
2024-11-06
Accepted
2024-11-06 16:01:26
Documents
81
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kant-20240930.htm   iXBRL 10-Q 2000781
2 EX-10.2 kant-ex10_2.htm EX-10.2 39841
3 EX-31.1 kant-ex31_1.htm EX-31.1 16607
4 EX-31.2 kant-ex31_2.htm EX-31.2 16714
5 EX-32.1 kant-ex32_1.htm EX-32.1 14975
  Complete submission text file 0000950170-24-122237.txt   9305505

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kant-20240930.xsd EX-101.SCH 1681249
84 EXTRACTED XBRL INSTANCE DOCUMENT kant-20240930_htm.xml XML 1475914
Mailing Address 7683 SE 27TH STREET SUITE 481 MERCER ISLAND WA 98040
Business Address 7683 SE 27TH STREET SUITE 481 MERCER ISLAND WA 98040 (206) 378-0400
KINETA, INC./DE (Filer) CIK: 0001445283 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 241430777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)